The in vitro and in vivo results suggested that UBA2 might play a role in suppressing apoptosis during ccRCC progression, and thus, inhibiting UBA2 expression may be a strategy to prevent the malignant proliferation of cancer cells. Here, UBA2 is linked to cancer.